arca biopharma inc
(ABIO:Consolidated Issue listed on NASDAQ Capital Market)
Transactions by ARCA BIOPHARMA INC (ABIO) in the last 6 months
ARCA biopharma, Inc. (NasdaqCM:ABIO) announced that it has entered into a securities purchase agreement of 42,021,579 units at a price of $0.8805 per unit for gross proceeds of $37,000,000 on June 10, 2015. Each unit consists of one common share and 0.4 share purchase warrant. Each warrant entitles the holder to purchase one common share of the company at an exercise price of $0.8716 per share for a period of December 13, 2015, 180 days after the closing date, and ending ...
|No competitor information is available for ABIO.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|